| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/17/2006 | CN1772766A Acetylcholinesterase monoclonal antibody related to resisting apoptosis and its use |
| 05/17/2006 | CN1772765A Bionic affinity purifying process of interleukin I natural agonist |
| 05/17/2006 | CN1772756A Prepn process of peonol as active anticancer component |
| 05/17/2006 | CN1772755A Catechol sodium complex and its prepn and application in medicine for preventing and treating cancer and tumor |
| 05/17/2006 | CN1772751A Substituted oxazolidinones and their use in the field of blood coagulation |
| 05/17/2006 | CN1772733A Cyanopyrrolidine derivatives |
| 05/17/2006 | CN1772303A Nanometer magnetic powder-antibody targeting medicine for magneto thermical threrapy of malignant tumor |
| 05/17/2006 | CN1772300A Nanometer manetic powder for magnetothermical therapy and anti-CEA antibody target medicine |
| 05/17/2006 | CN1772291A Nanometer granule prepn of bufanin albumin and its prepn process |
| 05/17/2006 | CN1772290A Nanometer granule prepn of cinobufagin toxoprotein and its prepn process |
| 05/17/2006 | CN1772266A Compound anticancer Chinese medicine prepn and its prepn process |
| 05/17/2006 | CN1772262A Broad-spectrum cancer-treating Chinese medicine prepn and its prepn process |
| 05/17/2006 | CN1772255A Chinese medicine for treating liver cancer and carcinoma of pancreas |
| 05/17/2006 | CN1772254A Lung cancer treating Chinese medicine |
| 05/17/2006 | CN1772235A Chinese medicine for treating swelling and pain |
| 05/17/2006 | CN1772189A Auxiliary treating medicine for lung cancer in late stage |
| 05/17/2006 | CN1772122A Indian stringbush prepn with antiphlogistic and detoxicating functions |
| 05/17/2006 | CN1772110A Chinese medicine composition |
| 05/17/2006 | CN1772089A Freeze dried oldenlandia powder for injection and its prepn |
| 05/17/2006 | CN1772064A Leukemia treating medicine and its prepn |
| 05/17/2006 | CN1772056A Chinese medicine prepn for dispelling wind evil and relieving pain and its prepn process |
| 05/17/2006 | CN1772035A Freeze dried ginseng-astragalus powder for injection to strengthen body's resistance and its prepn |
| 05/17/2006 | CN1772022A Application of asafetida and volatile asafetida oil in preparing anticancer medicine |
| 05/17/2006 | CN1772007A Fermented aweto hypha tablet |
| 05/17/2006 | CN1771984A New use of extracellular polysaccharide of halophilous aphanothece |
| 05/17/2006 | CN1771982A Medicine for preventing oral cavity cancer and its prepn |
| 05/17/2006 | CN1771968A Ursolic acid fat emulsion injection and its prepn |
| 05/17/2006 | CN1771961A Oral Geftinat prepn |
| 05/17/2006 | CN1771954A Vinorelbine liposome micro ball injection and its prepn |
| 05/17/2006 | CN1771934A Medicine composite containing red clover prime and prunetin and its medicinal application |
| 05/17/2006 | CN1771932A Castor oil injection of low content polyethenoxy ether and ethanol injection of low content taxol |
| 05/17/2006 | CN1771931A Use of diterpene compound in preparingmedicines with synergistic effect to chemical therepy medicines |
| 05/17/2006 | CN1771925A Application of recombinant allophycocyanin in preparing medicine for treating liver cancer |
| 05/17/2006 | CN1771909A Fatty artemisinin emulsion and its prepn and application |
| 05/17/2006 | CN1256734C Method of sterilizing radioactive seeds |
| 05/17/2006 | CN1256347C Fusion protein of kininogen D5 and tumor necrosis factor related apoptosis-inducing ligand(D5-TRAIL), its preparation and use thereof |
| 05/17/2006 | CN1256336C Novel 4'-demethyl-4'-0-substituted-1-deoxypodophyllotoxin derivative and geometric isomer thereof, process for preparation thereof and anti-cancer composition comprising same |
| 05/17/2006 | CN1256331C Heteropolyacid 5-fluorouracil antineoplastic and method for synthesizing the same |
| 05/17/2006 | CN1256324C Pyrrolidine derivatives as factor Xa inhibitors |
| 05/17/2006 | CN1256308C Yew genus plant extract and its extraction method and application |
| 05/17/2006 | CN1256146C Aqueous formulations of LHRH related peptide compound and preparing method and use thereof |
| 05/17/2006 | CN1256140C Chinese medicine for treating liver cancer |
| 05/17/2006 | CN1256113C Chinese medicine for treating tumor and preparing method thereof |
| 05/17/2006 | CN1256101C Method for preparing novel anti-cancer medicine |
| 05/17/2006 | CN1256096C Local applied medicine composition for curing subcutaneous tumor |
| 05/17/2006 | CN1256091C Adriacin or adriacin hydrochloride liposome injection and its preparing process |
| 05/17/2006 | CN1256087C Application of aloelactone in preparation of medicine |
| 05/17/2006 | CN1256081C Method for preparing injection of oleum functus brucease |
| 05/16/2006 | US7045660 [di(ether or thioether)heteroaryl or fluoro substituted aryl] compound or an N-oxide thereof or a salt thereof, useful for inhibiting the production or physiological effects of TNF in treatment of a patient suffering from a disease state associated with a detrimental excess of tumor necrosis factor |
| 05/16/2006 | US7045631 Substituted 2-thio-3, 5-dicyano-4-phenyl-6-aminopyridines and their use as adenosine receptor-selective ligands |
| 05/16/2006 | US7045616 Expression vector coding polypeptides for use in the treatment of alzheimer's dieases and tumors |
| 05/16/2006 | US7045613 IKK-αproteins, nucleic acids and methods |
| 05/16/2006 | US7045606 Chelate compound containing ligand with steroids, enzymes, hapten and antibodies |
| 05/16/2006 | US7045605 genetic engineered antibodies, nucleic acids; anticancer agents |
| 05/16/2006 | US7045604 Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 05/16/2006 | US7045596 Family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof |
| 05/16/2006 | US7045540 Selective estrogen receptor modulators |
| 05/16/2006 | US7045539 Therapeutic benzoxazole compounds |
| 05/16/2006 | US7045528 Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 05/16/2006 | US7045520 Opioid receptor active compounds |
| 05/16/2006 | US7045509 Proteins and nucleic acids encoding same |
| 05/16/2006 | US7045505 Isolation nucleic acids; genetic engineering; diagnosis, therapy, prevention hematopoietic, nervous system disorders |
| 05/16/2006 | US7045500 Comprises peptide with heparin and/or lipopolysaccharide binding activity for use as treatment of endotoxic shock and endometriosis, anticoagulant, angiogenesis inhibitor, antiproliferative agent and contraceptive |
| 05/16/2006 | US7045345 G-coupled receptor showing selective affinity for ATP |
| 05/16/2006 | US7045335 Immunotherapy; genetic engineering; anticancer agents |
| 05/16/2006 | US7045302 Expressed ligand-vascular intercellular signaling molecule |
| 05/16/2006 | US7045299 Digestive diseases; amino acid sequence 20 or 21; specific to orphan receptor protein ZAQ |
| 05/16/2006 | US7045283 Detecting preferential ligands in cell; obtain cell, incubate with reporter molecules, detect reporter in cell |
| 05/16/2006 | US7045280 Assay method |
| 05/16/2006 | US7045155 Phytooestrogen selected from genistein, daidzein; for promoting health in cases of cancer, pre-menstrual syndrome, menopause or hypercholesterolaemia |
| 05/16/2006 | US7045140 Therapeutic delivery of carbon monoxide |
| 05/16/2006 | US7045129 Method of treating cancer including administering a human chimeric antibody specific for the ganglioside GD3 |
| 05/16/2006 | US7045115 Drugs for the diagnosis of tissue-reproductive activity or the treatment of proliferative diseases |
| 05/16/2006 | CA2197628C Substituted thiophenylalkenylcarboxylic acid guanidides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 05/16/2006 | CA2192797C Indolinone compounds for the treatment of disease |
| 05/16/2006 | CA2129183C Bispecific trigger molecules recognizing lymphocyte antigen cd2 and tumor antigens |
| 05/11/2006 | WO2006050506A1 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 05/11/2006 | WO2006050461A1 Use of an mtor inhibitor in treatment of uterine leiomyoma |
| 05/11/2006 | WO2006050249A1 Diaminotriazole compounds useful as inhibitors of protein kinases |
| 05/11/2006 | WO2006049339A1 Novel fused imidazole derivative |
| 05/11/2006 | WO2006049157A1 Multimeric oleamide derivative having connexin-26 inhibiting potency and use thereof in cancer therapy, etc. |
| 05/11/2006 | WO2006048891A1 Method of stabilizing and potentiating the action of anti-angiogenic substances |
| 05/11/2006 | WO2006048862A2 The use of a protease or a protease inhibitor for the manufacture of medicaments |
| 05/11/2006 | WO2006048768A2 Kit of parts designed for implementing an antitumoral or antiviral treatment in a mammal |
| 05/11/2006 | WO2006048751A1 Polymorphic forms of 6-[2-(methylcarbamoyl)phenylsulfanyl]-3-e-[2-(pyridin-2-yl)ethenyl]indazole |
| 05/11/2006 | WO2006048744A1 Methods of preparing indazole compounds |
| 05/11/2006 | WO2006048633A2 Combination comprising zd6474 and an antiandrogen |
| 05/11/2006 | WO2006048473A1 β-LACTAMIC RGD CYCLOPEPTIDES CONTAINING GAMMA (Ϝ) TURNS |
| 05/11/2006 | WO2006048308A1 Quinazoline derivatives, process for their preparation, their use as antimitotics and pharmaceutical compositions comprising said derivatives |
| 05/11/2006 | WO2006047931A1 The use of dipyridamole in manufacturing the anti-malignant tumor medicines |
| 05/11/2006 | WO2006047891A1 Polycyclic aromatics and derivatives thereof and processes for their preparation |
| 05/11/2006 | WO2006047878A1 Cancer therapeutics and methods for their use |
| 05/11/2006 | WO2006029018A3 Combinatorial chemotherapy treatment using na+/k+-atpase inhibitors |
| 05/11/2006 | WO2006014282A3 Prodrugs of hiv protease inhibitors |
| 05/11/2006 | WO2006013472A3 Novel anti-igf-ir antibodies and uses thereof |
| 05/11/2006 | WO2006005759A3 Mitochondrially targeted antioxidants in the treatment of liver diseases and epithelial cancers |
| 05/11/2006 | WO2005106471A3 Diagnostics and therapeutics for diseases associated with c-c chemokine receptor 4 (ccr4) |
| 05/11/2006 | WO2005089731A3 Use of renin inhibitors in therapy |
| 05/11/2006 | WO2005003177A3 Molecules for the targeting and the in situ assembly of therapeutic proteins and use thereof |
| 05/11/2006 | WO2002098351A8 Novel method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within mmp-2 |